Avanos Medical (AVNS) Net Margin (2013 - 2026)

Avanos Medical (AVNS) posted Net Margin of 2.8% for Q1 2026, up 1775.74% sequentially from 0.17% in Q4 2024.

Avanos Medical (AVNS) Net Margin (2013 - 2026) Analysis & Trends

Avanos Medical has reported Net Margin for 12 years, with the latest figure at 2.8% in Q1 2026.

Quarterly Net Margin changed N/A year-over-year to 2.8% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.71% (up 135.0% YoY) and the FY2024 annual result came in at 0.84%, up 687.0% from the prior year.
Net Margin advanced to 2.8% in Q1 2026 per AVNS's latest filing, from 0.17% in the prior quarter.
Over five years, Net Margin peaked at 4.58% in Q1 2023 and troughed at 37.66% in Q2 2023.
A 4-year average of 1.31% and a median of 2.73% in 2022 frame the typical range for Net Margin.
The sharpest annual moves came in 2022 and 2023: Net Margin jumped 7575 bps in 2022, then plunged 4217 bps in 2023.
Over 4 years, Net Margin stood at 3.96% in 2022, then plunged by 107 bps to 0.29% in 2023, then soared by 42 bps to 0.17% in 2024, then surged by 1776 bps to 2.8% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 2.8%, 0.17%, and 0.94% for Q1 2026, Q4 2024, and Q3 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn	7.37%
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn	19.37%
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn	12.84%
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn	16.67%
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn	13.87%
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	19.04%
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	10.84%
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	6.47%
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn	13.47%
10	Avanos Medical	1.17 Bn	1.10 Bn	94.20 Mn	2.80%

Download Data